18 November 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics identifies predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
Optimal duration of anti-viral therapy in chronic hepatitis B virus infection remains unclear.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors